Walleye Capital’s Aspen Aerogels ASPN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-100
Closed -$283 4370
2025
Q4
$283 Buy
+100
New +$516 ﹤0.01% 4415
2025
Q3
Sell
-27,400
Closed -$162K 4474
2025
Q2
$162K Sell
27,400
-6,600
-19% -$38K ﹤0.01% 3515
2025
Q1
$217K Buy
34,000
+10,800
+47% +$104K ﹤0.01% 3209
2024
Q4
$276K Buy
23,200
+20,900
+909% +$356K ﹤0.01% 3491
2024
Q3
$63.7K Buy
2,300
+200
+10% +$5K ﹤0.01% 4561
2024
Q2
$50.1K Buy
+2,100
New +$49.3K ﹤0.01% 4927
2024
Q1
Sell
-20,500
Closed -$323K 5402
2023
Q4
$323K Buy
20,500
+11,400
+125% +$118K ﹤0.01% 3319
2023
Q3
$78.3K Buy
+9,100
New +$64.6K ﹤0.01% 4039

Other funds holding ASPN

Walleye Capital's ASPN Position: Q1 2026 in Review

Walleye Capital sold out of Aspen Aerogels (ASPN) in Q1 2026, closing a stake of 834 shares — an estimated $2.81K sold.

Walleye Capital first reported a position in ASPN in Q4 2021 and held it in 8 quarters. The position peaked at $1.65M in Q2 2024. 166 funds tracked by Wall St. Rank hold ASPN as of Q1 2026.

  • Walleye Capital reported no remaining Aspen Aerogels position as of Q1 2026 after selling out during the quarter.
  • Walleye Capital sold 834 Aspen Aerogels shares in Q1 2026, an estimated $2.81K.
  • Walleye Capital first reported a position in Aspen Aerogels in Q4 2021 and held it in 8 quarters.
  • Walleye Capital's Aspen Aerogels position peaked at $1.65M in Q2 2024.
  • 166 funds tracked by Wall St. Rank held Aspen Aerogels as of Q1 2026.

Based on Walleye Capital's 13F filing for Q1 2026, filed 11 May 2026.